Lessons Learnt from Assembling Screening Libraries for Drug Discovery for Neglected Diseases

To enable the establishment of a drug discovery operation for neglected diseases, out of 2.3 million commercially available compounds 222 552 compounds were selected for an in silico library, 57 438 for a diverse general screening library, and 1 697 compounds for a focused kinase set. Compiling thes...

Descripción completa

Detalles Bibliográficos
Autores principales: Brenk, Ruth, Schipani, Alessandro, James, Daniel, Krasowski, Agata, Gilbert, Ian Hugh, Frearson, Julie, Wyatt, Paul Graham
Formato: Texto
Lenguaje:English
Publicado: WILEY-VCH Verlag 2008
Materias:
Full Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2628535/
https://www.ncbi.nlm.nih.gov/pubmed/18064617
http://dx.doi.org/10.1002/cmdc.200700139

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2628535/
https://www.ncbi.nlm.nih.gov/pubmed/18064617
http://dx.doi.org/10.1002/cmdc.200700139

Ejemplares similares